Saturday, December 27, 2008

Top 10 Cosmetic Surgery Trends for 2009

The American Society for Aesthetic Plastic Surgery (ASAPS), offers its predictions for cosmetic surgery in 2009. Predictions are based on interviews with leading plastic surgeons around the country.

1. Aesthetic Medicine has seen a dramatic increase in the diversity of the patients treated over the past decade and this trend is expected to continue to grow stronger than ever, with applications that cater to all people. The appeal of both aesthetic surgery and cosmetic medicine will continue to spread across the spectrum of our population, as plastic surgeons from the medical industry further tailor treatments to meet the sometimes unique needs of that expanding population.

2. The growth and popularity of cosmetic fillers (Evolence, Juvederm, Restylane, etc.) will continue to increase as products continue to evolve and new players enter the market.

3. As our population increasingly realizes the dangers and health consequences of obesity, the number of patients seeking plastic surgery procedures for body contouring after dramatic weight loss (abdominoplasty, lower body lift, upper arm lift, etc.) will rise in 2009.

4. Reloxin (an injectable form of Botulinum Toxin Type A) will gain FDA approval and compete with Botox (the most popular cosmetic procedure for the past 5 years) and other similar products may begin to enter pre-market clinical trials.

5. Consumers looking for a bargain on cosmetic procedures will unfortunately lead to an increase in horror stories about “discount injectables” bought offshore and cosmetic medicine and cosmetic surgical procedures performed by untrained or poorly trained practitioners.

6. Experimental techniques for non-invasive fat removal (SonoScultpt, UltraShape) as a future alternative or adjunct to liposuction (lipoplasty) surgery, will continue be tested in clinical trials.

7. Men will represent a growing segment of the aesthetic surgery market. (According to a February 2008 consumer survey commissioned by ASAPS, 57 percent of men approve of cosmetic surgery, and 20 percent would consider having cosmetic surgery. Seventy-nine percent (79%) of American men surveyed said they would not be embarrassed if people in addition to their family and close friends knew they had undergone cosmetic surgery.)

8. As the popularity of non surgical and minimally invasive procedures continues to grow; surgeons and manufacturers will develop new techniques and products that advance the science, produce even better results and lessen recovery time.

9. Cosmetic surgery “vacations” will become less popular as educated consumers understand the safety and risk issues associated with surgical procedures and travel. Surgery performed by board-certified aesthetic plastic surgeons, in accredited facilities where follow-up care is available will continue to be the safest option and the best value.

10. Following the trend in increased consumer sophistication regarding healthcare choices, board certification of practitioners, and accreditation of surgical facilities will play an even more important role in choosing a cosmetic surgeon.

American Society for Aesthetic Plastic Surgery

Posts, Possibly of Interest

2009: Top 9 Issues for Health Industries

Hospital Reforms - A Must for the Future

How Dietary Supplements Can Save Billions

Friday, December 26, 2008

How Harmful Bacteria Can Fight off Cancer?

Back in 2004, an experimental cancer vaccine using modified listeria bacteria showed great promise in animal studies by successfully treating new cancers in mice. At present human clinical trials - a pharmaceutical service, are underway.

Listeria monocytogenes is a deadly bacterium commonly found in soil, stream water, sewage, plants, and food and is responsible for causing listeriosis – a lethal food-borne infection with a fatality rate of 25%. On the other hand, the Salmonella bacterium, which, some time back, made headlines by tainting tomatoes nationwide, has a less than 1% mortality rate. Further, the deadliness of listerosis is to some extent attributed to the infection's ability to spread to the nervous system causing meningitis.

Nevertheless, a genetically altered version of the scary pathogen raises hopes that an engineered listeria vaccine can target cancers such as pancreatic and ovarian cancer, and perhaps leukemia as well.

The Bacteria Therapy's Modus Operandi

The bacteria rev up our immune system's engines to act fiercely against cancer cells. First they incite an “inherent” response from the immune system, and second, cause the cancer antigens to seep into the cells, which stimulate a potent "acquired" immune response. Thus causing the immune system to step on the gas real hard.

This immune response so generated induce both inflammation and an immune response to specific tumor antigens thereby attacking the tumor with generalized antitumor chemicals including interferon and tumor necrosis factor, coupled with activated T-cells that attack and kill the tumor. And experts believe that Listeria is by far the best bug to induce that kind of a response, i.e. activating both the innate and acquired immunity to work in tandem.

Phase I/II clinical trials pharmaceutical service results have shown that the live Listeria cancer vaccine “Lovaxin” by Advaxis is safe for humans. The trials though meant to assess safety also found that six of the 15 treated patients were still alive 2 years compared to their their life expectancy at the beginning of the trial that was six months or less.

As research continues, the deadly bacteria may eventually turnout to be a helpful buddy.

Posts, Possibly of Interest

How Some Vegetables Fight Cancer

Cough Drug Ingredient May Treat Prostate Cancer

Do Vitamin Supplements Prevent Cancer?

Smoking May Up Colorectal Cancer Risk & Death

Low-income men more likely to be diagnosed with advanced prostate cancer

How Happiness May Prevent Breast Cancer?

The Power of Naturals Against Cancer

Moisturized Mice Mean Skin Cancer - Do They?

Breast Cancer Disclosure: An Emotional Battle for Women

Wednesday, December 24, 2008

How Some Vegetables Fight Cancer

Women should go for the broccoli when the relish tray comes around during holiday celebrations this season.

While it has been known for some time that eating cruciferous vegetables, such as broccoli, cauliflower, and cabbage, can help prevent breast cancer, the mechanism by which the active substances in these vegetables inhibit cell proliferation was unknown — until now.

Scientists in the UC Santa Barbara laboratories of Leslie Wilson, professor of biochemistry and pharmacology, and Mary Ann Jordan, adjunct professor in the Department of Molecular, Cellular, and Developmental Biology, have shown how the healing power of these vegetables works at the cellular level. Their research is published in this month's medical industry journal Carcinogenesis.

"Breast cancer, the second leading cause of cancer deaths in women, can be protected against by eating cruciferous vegetables such as cabbage and near relatives of cabbage such as broccoli and cauliflower," said first author Olga Azarenko, who is a graduate student at UCSB. "These vegetables contain compounds called isothiocyanates which we believe to be responsible for the cancer-preventive and anti-carcinogenic activities in these vegetables. Broccoli and broccoli sprouts have the highest amount of the isothiocyanates.

Sulforaphane or SFN,.. has already been shown to reduce the incidence and rate of chemically induced mammary tumors in animals. It inhibits the growth of cultured human breast cancer cells, leading to cell death.

SFN like the more powerful anticancer agents,..[works] in a similar manner to the more powerful anticancer drugs. However SFN is much weaker than these other plant-based drugs, and thus much less toxic.

"SFN may be an effective cancer preventive agent because it inhibits the proliferation and kills precancerous cells," said Wilson. It is also possible that it could be used as an addition to taxol and other similar drugs to increase effective killing of tumor cells without increased toxicity.

EurekaAlert

Posts, Possibly of Interest

Cough Drug Ingredient May Treat Prostate Cancer

Do Vitamin Supplements Prevent Cancer?

Study: Lower Death Rates Linked to Drug Eluting Stents

Monday, December 22, 2008

Least Heart Failure Risk for the Lean and Active

According to research conducted by doctors of the Brigham and Women's Hospital in Boston and their colleagues assessing heart failure risk, found that the lean and active groups had the least risk, while the inactive group had the highest risk.

Also, even engaging in vigorous physical activity just about 1 to 3 times a month can make a difference by reducing risk of heart failure by a good 18 percent.

The results will be published in the Jan. 6 issue of the medical publication - Circulation: Journal of the American Heart Association.


Do Vitamin Supplements Prevent Cancer?

During the last decade, vitamin supplements appeared to be quite encouraging as potential remedies against cancer, heart disease, stroke and several other maladies. Recently, long-term studies carried out to determine their efficacy against cancer showed that vitamin dietary supplements weren't effective. So now do we have definitive evidence against the use of vitamin supplements in preventing cancer, some experts disagree.

More at: Themedica

Thursday, December 18, 2008

Cough Drug Ingredient May Treat Prostate Cancer

A study published today in the December issue of the European medical journal Anticancer Research demonstrates that an ingredient used in a common cough suppressant may be useful in treating advanced prostate cancer. Researchers found that noscapine, which has been used in cough medication for nearly 50 years, reduced tumor growth in mice by 60% and limited the spread of tumors by 65% without causing harmful side effects.

Prostate cancer is the most common cancer among men in the United States. The American Cancer Society estimates that 186,320 men will be diagnosed with prostate cancer in 2008 and 28,660 will die from it. One man in 6 will get prostate cancer during his lifetime. Although slow-growing in most men, the cancer is considered advanced when it spreads beyond the prostate. There is no known cure. And low income men are at an increased risk of advanced prostate cancer

Noscapine is a naturally-occurring substance, a non-addictive derivative of opium found in cough medicines. As a natural substance, noscapine cannot be patented, which has limited the potential for clinical trials.

Hormone therapy and chemotherapy, along with radiation and surgery, are currently used to slow the progression of advanced prostate cancer. Side effects resulting from these treatments include impotence, incontinence, fatigue, anemia, brittle bones, hair loss, reduced appetite, nausea and diarrhea. No toxic side effects were observed in the laboratory study of noscapine.

Find the story at EurekaAlert!

Posts, Possibly of Interest

Phony Patients may Avert Adverse Drug Events

Smoking May Up Colorectal Cancer Risk & Death

2009: Top 9 Issues for Health Industries

Robotic Pharmacists – Drug Dispensing Made Easy

Pharmacists have a tough job, aside from reading illegible prescriptions, and ensuring that only the right pharmaceutical drugs are dispensed, they have to constantly run around stockrooms looking for drugs. However, some pharmacies may have already found a solution in the form of robotic pharmacists.

Recently, a new set of robotic dispensers, christened as “robodispensers,” were introduced at Leicester's hospitals' pharmacies. These robots are big machines, about eight meters in size, and are costly too, with each piece costing about US$ 463,530.

The New Age Dispensers

The new age pharmacists seem to be clever and efficient machines, as they can tirelessly work round the clock and not need even a cat's nap. They can accurately locate and dispense 700 medicines a day - 60 per hour, in addition to storing 25,000 packs of medicines.

When a pharmacy technician asks the robots to fetch a pack of a particular pharmaceutical – patent or a generic drug, the on-board computer swings into action, calculating where the medicines are stocked. Next, the picking head gets to right spot, and using a suction arm pulls the pack from the shelf. After which the pack find its way onto a conveyor belt and the drugs are delivered to the technician.

Bulky and pricey they may be, however they have a number of advantages over human pharmacists. For instance, they can save many pharmacists the pain of rushing about stockrooms in search of medicines, and they can better focus on ensuring that the right medicines are dispensed. Also, these robotic dispensers are highly accurate because rely on the barcodes on the prescription drugs packs to identify medicines, thus reducing errors. And, a reduced turnaround time is yet another benefit.

Perhaps, reduced costs and widespread installations of such machines will take care of the woes of pharmacy technicians around the world.

Posts, Possibly of Interest

Assistive Technology – Robots are the Future

Low-carb diets Can Lead to Poor Thinking

Phony Patients may Avert Adverse Drug Events